Dolan R T, Butler J S, Murphy S M, Cronin K J
Department of Plastic and Reconstructive Surgery, Mater Misericordiae University Hospital, Dublin, Ireland.
Ann R Coll Surg Engl. 2012 Jan;94(1):43-51. doi: 10.1308/003588412X13171221498749.
Microvascular free flap reconstruction has revolutionised the reconstruction of complex defects of traumatic, oncological, congenital and infectious aetiologies. Complications of microvascular free flap procedures impact negatively on patient post-operative course and outcome.
We performed a retrospective analysis of 102 consecutive patients undergoing 108 free flap procedures at a tertiary referral centre over an 8-year period. Logistic regression analysis was used to identify factors predictive of free flap complications. Health-related quality of life (HRQoL) and aesthetic outcomes were assessed using the Short Form 36 questionnaire and a satisfaction visual analogue scale respectively.
In total, 108 free tissue transfers were performed; 23% were fasciocutaneous free flaps, 69% musculocutaneous and 8% osteoseptocutaneous. The overall flap success rate was 92.6%. Over a third of patients (34.3%) had flap-related complications ranging from minor wound dehiscence to total flap loss. ASA (American Society of Anesthesiologists) grade ≥2 (OR: 16.9, 95% CI: 15.3-18.1, p<0.009), history of smoking (OR: 6.1, 95% CI: 5.5-7.2, p<0.049), body mass index ≥25 kg/m(2) (OR: 21.3, 95% CI: 20.8-22.1, p<0.003), low albumin (odds ratio [OR]: 2.2, 95% confidence interval [CI]: 1.2-3.9, p<0.003) and peripheral vascular disease (OR: 6.9, 95% CI: 5.9-7.5, p<0.036) were identified as factors independently predictive of free flap complications.
Patients undergoing uncomplicated free flap surgery and those reporting superior post-operative flap aesthesis have higher HRQoL scores. Microvascular free tissue transfer has revolutionised our approach to the reconstruction of complex defects, providing a safe, reliable procedure to restore functionality and quality of life for patients.
微血管游离皮瓣重建术彻底改变了对创伤性、肿瘤性、先天性和感染性病因导致的复杂缺损的重建方式。微血管游离皮瓣手术的并发症会对患者的术后病程和结局产生负面影响。
我们对一家三级转诊中心在8年期间连续进行108例游离皮瓣手术的102例患者进行了回顾性分析。采用逻辑回归分析来确定游离皮瓣并发症的预测因素。分别使用简短健康调查问卷(Short Form 36 questionnaire)和满意度视觉模拟量表对健康相关生活质量(HRQoL)和美学效果进行评估。
共进行了108例游离组织移植;其中23%为筋膜皮瓣游离皮瓣,69%为肌皮瓣,8%为骨膜皮瓣。皮瓣总体成功率为92.6%。超过三分之一的患者(34.3%)出现了与皮瓣相关的并发症,从轻微伤口裂开至皮瓣完全坏死。美国麻醉医师协会(ASA)分级≥2(比值比[OR]:16.9,95%置信区间[CI]:15.3 - 18.1,p < 0.009)、吸烟史(OR:6.1,95% CI:5.5 - 7.2,p < 0.049)、体重指数≥25 kg/m²(OR:21.3,95% CI:20.8 - 22.1,p < 0.003)、低白蛋白(比值比[OR]:2.2,95%置信区间[CI]:1.2 - 3.9,p < 0.003)和外周血管疾病(OR:6.9,95% CI:5.9 - 7.5,p < 0.036)被确定为游离皮瓣并发症的独立预测因素。
接受无并发症游离皮瓣手术的患者以及报告术后皮瓣美学效果良好的患者具有更高的健康相关生活质量评分。微血管游离组织移植彻底改变了我们对复杂缺损重建的方法,为患者恢复功能和生活质量提供了一种安全、可靠的手术方式。